Product Information
HUMIRA(CF) 20 MG/0.2 ML SYRINGE is a brand product labeled by AbbVie Inc., priced at $3366.1230 per EA under NDC 00074061602. Its NADAC has been published 115 times since Apr 17, 2024.
Manufacturer
AbbVie Inc.NDC
00074061602
Classification
Brand
Dosage Form
KIT
Last Updated
5/20/2026
Approval Type
Biologic (BLA)
FDA Application
BLA125057On Market Since
4/28/2017
Price Statistics
The NADAC for HUMIRA(CF) 20 MG/0.2 ML SYRINGE has been published 115 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $3366.1230 per EA |
|---|---|
| All-time high | $3374.7750 (Aug 13, 2025) |
| All-time low | $3340.6945 (Feb 19, 2025) |
| 52-week high | $3374.7750 |
| 52-week low | $3366.1230 |
| Median price | $3367.2756 |
| Average price | $3363.5334 |
| Largest weekly change | +0.8% (Jun 18, 2025) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of HUMIRA(CF) 20 MG/0.2 ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for HUMIRA(CF) 20 MG/0.2 ML SYRINGE, manufactured by AbbVie Inc., is $3366.1230 per EA (NDC 00074061602), effective Jun 24, 2026.
How has the price of HUMIRA(CF) 20 MG/0.2 ML SYRINGE changed over time?
Over the history we have for it, the NADAC for HUMIRA(CF) 20 MG/0.2 ML SYRINGE has held within roughly two percent of its current level. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for HUMIRA(CF) 20 MG/0.2 ML SYRINGE?
Since Apr 17, 2024, the NADAC for HUMIRA(CF) 20 MG/0.2 ML SYRINGE has ranged from a low of $3340.6945 (Feb 19, 2025) to a high of $3374.7750 (Aug 13, 2025), with a median of $3367.2756 per EA.
Are there cheaper alternatives to HUMIRA(CF) 20 MG/0.2 ML SYRINGE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as HUMIRA(CF) 20 MG/0.2 ML SYRINGE, but none are currently priced below it.
Who manufactures HUMIRA(CF) 20 MG/0.2 ML SYRINGE?
HUMIRA(CF) 20 MG/0.2 ML SYRINGE (NDC 00074061602) is labeled by AbbVie Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification